Generic drugs are non-brand-name medications that are typically cheaper because they are produced after the original drug’s patent expires. Price caps limit how much pharmaceutical companies can charge for these generic versions, aiming to keep them affordable for patients. Proponents argue that removing price caps promotes market competition, can spur innovation in the generic drug market, and may lead to better supply and availability. Opponents argue that eliminating caps could result in significant price increases, putting essential medications out of reach for low-income or uninsured patients.
Statistics are shown for this demographic
Voting for candidate
State Senate District
Trend of support over time for each answer from 16.2k America voters.
Loading data...
Loading chart...
Trend of how important this issue is for 16.2k America voters.
Loading data...
Loading chart...
Unique answers from America voters whose views went beyond the provided options.
@B3HQLYW1yr1Y
@B5X329R12mos12MO
@2KJVWFY 6mos6MO
@B7JWKV49mos9MO
The government should not fully eliminate price caps on generics — but instead reform them. Essential medicines need caps for affordability, but manufacturers also need incentives and flexibility to avoid shortages. A hybrid approach (caps + subsidies + import competition) balances affordability and supply.
@BDZTDDD1wk1W
@BDVHHN63wks3W
@BDMHVM71mo1MO
@BDM4FCW1mo1MO
Join in on the most popular conversations.
Based on 16.2k responses to this question.
These results come from iSideWith's ongoing political issues survey. We collect over a million responses per day, filter out duplicate and multiple submissions, and break the results down by political party, ideology, age, state, and census demographics (income, race, education, household).
iSideWith is non-partisan — we don't advocate for any party, candidate, or position. We report what the public tells us.
Writing about this issue? Use the live data and link back to the full results.